Head-to-head · WeighScore
Shape Vantage vs Tablet Health
The verdict
Tablet Health takes it — 47.6/100 to 43/100.
Tablet Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Tablet Health is a DTC telehealth platform offering compounded semaglutide and tirzepatide in both injection and oral forms, with ED and NAD+ wellness lines as well.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Shape Vantage | Tablet Health |
|---|---|---|
| WeighScore | 43/100 | 47.6/100 |
| Grade | C | C |
| Scorecard rank | #499 | #495 |
| Semaglutide | Not disclosed | Not disclosed |
| Tirzepatide | $599/mo (compounded) | Not disclosed |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Yes |
Graded #499 · C
Strengths
- $599 product price shown publicly, not gated behind intake
- Terms of Service exists and discloses the legal relationship
- Positions itself as 'Premium Weight Loss Treatment'
Where it loses points
- Homepage uses a dietary-supplement-style disclaimer, not language seen on legitimate prescription products
- Links straight to a Stripe checkout with no medical intake, consultation, or prescription gate
- Terms reserve the option to ship without prescription or provider review where not legally required
- No LegitScript, NABP, state-pharmacy, or PCAB accreditation visible
- Legal entity and state of incorporation not disclosed (only California governing law)
Graded #495 · C
Strengths
- LegitScript Certified
- Four named compounding pharmacy partners (Pharmacy Hub, Epiq Scripts, Dr. TelX, Emerad), none with FDA warning letters
- Oral GLP-1 option for both semaglutide and tirzepatide — uncommon in compounded telehealth
- Mid-tier pricing starting $179–$299/mo across all four product variants
- No commitment — cancel anytime
Where it loses points
- States served not published — you must complete the intake quiz to learn eligibility
- No founder, CEO, medical director, or pharmacist-in-charge named anywhere
- No BBB profile found
- Its Queens NYC pharmacy is 'opening soon' — all dispensing currently routes through external partners
- FDA issued this company a warning letter dated 19 March 2025; the letter is public in FDA's warning-letter database
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.